SetPoint Medical Stock
HealthTechLooking to sell SetPoint Medical stock or options?
SetPoint Medical has developed an implantable bioelectronic medical device aimed at modulating neuroimmune pathways to decrease inflammation and restore immune balance in chronic autoimmune disorders. This innovative technology offers targeted electrical stimulation to the vagus nerve via a compact, wireless implant that is programmed for automatic daily therapy with minimal upkeep. By providing an alternative to traditional drug treatments, it enables healthcare providers and patients managing autoimmune diseases like rheumatoid arthritis to potentially experience reduced risks and treatment burdens.